Y Mabs Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Y Mabs Therapeutics (YMAB) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Y Mabs Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Y Mabs Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Y Mabs Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $507k | 31k | 16.26 |
| 2023-12-31 | $282k | 41k | 6.82 |
| 2023-09-30 | $177k | 33k | 5.45 |
| 2023-06-30 | $262k | 39k | 6.79 |
| 2023-03-31 | $832k | 167k | 4.97 |
| 2022-12-31 | $160k | 33k | 4.88 |
| 2022-06-30 | $494k | 33k | 15.12 |
| 2022-03-31 | $503k | 42k | 11.88 |
| 2021-12-31 | $610k | 38k | 16.23 |
| 2021-03-31 | $964k | 32k | 30.21 |
| 2020-12-31 | $1.5M | 30k | 49.53 |
| 2020-09-30 | $1.2M | 30k | 40.47 |
| 2020-06-30 | $1.4M | 31k | 43.18 |
| 2020-03-31 | $848k | 33k | 26.12 |
| 2019-12-31 | $1.1M | 34k | 31.28 |
| 2019-09-30 | $917k | 35k | 26.06 |
| 2019-06-30 | $739k | 33k | 22.26 |
| 2019-03-31 | $802k | 30k | 26.67 |
| 2018-12-31 | $637k | 31k | 20.34 |
| 2018-09-30 | $798k | 30k | 26.56 |